AMR Sept Banner v2

ASM Attends UN General Assembly

ASM President, Susan Sharp, Ph.D., joined global leaders at the United Nations General Assembly in New York today in a historical meeting to focus on the commitment to fight AMR.
Read

UN General Assembly Focuses on AMR

Leaders at the UN General Assembly draft a plan for coordinated, cross-cutting efforts to improve the current state of AMR.
Read

Superbugs are a 'Fundamental Threat'

If antibiotics were telephones, we would still be calling each other using clunky rotary dials and copper lines," Stefano Bertuzzi, CEO of ASM, told NBC News.
Read
Become a member today!
JOIN ASM
Submit Abstracts for Biothreats 2017
SUBMIT
Antibacterial Development Conference
REGISTER

rosen hughDr. Rosen is Professor of Chemical Physiology at The Scripps Research Institute. He received his M.D. from the University of Cape Town and his Ph.D. from Oxford. His laboratory uses chemical approaches to define control points in immune function that shed light on mechanisms and treatments for autoimmunity and viral immunopathology. Work with colleagues Michael Oldstone, Ray Stevens and Ed Roberts has led to the discovery of chemical agonists and antagonists for the sphingosine 1-phophate receptor system that has defined a new chemically-tractable mechanism for the amelioration of influenza immunopathology, a high resolution crystal structure of the S1P1 receptor, and a potential treatment for multiple sclerosis now in Phase I clinical studies that derived from a lead discovered in the NIH Compound Repository, part of the Molecular Libraries Initiative of the NIH Roadmap (http://mli.nih.gov/mli/secondary-menu/news-events/).

 

The labs activities can be found at http://www.scripps.edu/chemphys/rosen/ and the activities at the Scripps Research Institute Molecular Screening Center at http://mlpcn.florida.scripps.edu/

TPL_asm2013_SEARCH

91132